SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-019236
Filing Date
2019-05-15
Accepted
2019-05-14 20:41:01
Documents
68
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q stro-10q_20190331.htm 10-Q 2097981
2 EX-31.1 stro-ex311_9.htm EX-31.1 16148
3 EX-31.2 stro-ex312_7.htm EX-31.2 16155
4 EX-32.1 stro-ex321_8.htm EX-32.1 6611
5 EX-32.2 stro-ex322_6.htm EX-32.2 6641
  Complete submission text file 0001564590-19-019236.txt   7753373

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stro-20190331.xml EX-101.INS 1645648
7 XBRL TAXONOMY EXTENSION SCHEMA stro-20190331.xsd EX-101.SCH 65517
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stro-20190331_cal.xml EX-101.CAL 37021
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stro-20190331_def.xml EX-101.DEF 272478
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20190331_lab.xml EX-101.LAB 477755
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20190331_pre.xml EX-101.PRE 393565
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 19824732
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences